ReviewDrugs2017

Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies.

Kevin A Hay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.